Mevalonate kinase: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
== Structural highlights == | == Structural highlights == | ||
The 3D structure of MK complex with mevalonate shows the enzyme composed of <scene name='86/864102/Cv/2'>2 domains</scene>: The N-terminal and the C-terminal. The mevalonate binds in a <scene name='86/864102/Cv/ | The 3D structure of MK complex with mevalonate shows the enzyme composed of <scene name='86/864102/Cv/2'>2 domains</scene>: The N-terminal and the C-terminal. The mevalonate binds in a <scene name='86/864102/Cv/5'>deep cleft</scene> between the 2 domains forming H-bond interactions with Arg and Tyr residues and several hydrophobic interactions<ref>PMID:17397541</ref>. | ||
==3D structures of mevalonate kinase== | ==3D structures of mevalonate kinase== | ||
Revision as of 16:18, 13 October 2020
FunctionMevalonate kinase (MK) is the first enzyme in the mevalonate pathway which synthesizes sterol isoprenoids like cholesterol and non-sterol isoprenoids like ubiquinone[1]. MK catalyzes the conversion of mevalonate to 5-phosphomevalonate. DiseaseMutations in MK resulting in MK deficiency cause hyperimmunoglobulinenemia D, a type of severe early-onset colitis, characterized by abdominal pain, diarrhea and vomiting[2]. RelevanceStructural highlightsThe 3D structure of MK complex with mevalonate shows the enzyme composed of : The N-terminal and the C-terminal. The mevalonate binds in a between the 2 domains forming H-bond interactions with Arg and Tyr residues and several hydrophobic interactions[3]. 3D structures of mevalonate kinaseUpdated on 05-May-2025 2r3v - hMK - human 2r42 - rMK + farnesyl thiopyrophosphate- rat
|
| ||||||||||
ReferencesReferences
- ↑ Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007 Jun;40(9-10):575-84. doi: 10.1016/j.clinbiochem.2007.03.016., Epub 2007 Mar 31. PMID:17467679 doi:http://dx.doi.org/10.1016/j.clinbiochem.2007.03.016
- ↑ Levy M, Arion A, Berrebi D, Cuisset L, Jeanne-Pasquier C, Bader-Meunier B, Jung C. Severe early-onset colitis revealing mevalonate kinase deficiency. Pediatrics. 2013 Sep;132(3):e779-83. doi: 10.1542/peds.2012-3344. Epub 2013 Aug, 26. PMID:23979089 doi:http://dx.doi.org/10.1542/peds.2012-3344
- ↑ Sgraja T, Smith TK, Hunter WN. Structure, substrate recognition and reactivity of Leishmania major mevalonate kinase. BMC Struct Biol. 2007 Mar 30;7:20. PMID:17397541 doi:10.1186/1472-6807-7-20